- Report
- May 2025
- 267 Pages
Global
From €4391EUR$4,950USD£3,812GBP
- Report
- October 2024
- 122 Pages
Global
From €4125EUR$4,650USD£3,581GBP
- Report
- February 2025
- 180 Pages
Global
From €3992EUR$4,500USD£3,466GBP
- Report
- October 2025
- 185 Pages
Global
From €3145EUR$3,545USD£2,730GBP
€3494EUR$3,939USD£3,034GBP
- Report
- October 2025
- 282 Pages
Global
From €5189EUR$5,850USD£4,505GBP
- Report
- October 2025
- 220 Pages
Global
From €5189EUR$5,850USD£4,505GBP
- Report
- March 2025
- 175 Pages
Global
From €3983EUR$4,490USD£3,458GBP
- Report
- May 2025
- 114 Pages
Global
From €4213EUR$4,750USD£3,658GBP
- Report
- August 2025
- 147 Pages
Global
From €3504EUR$3,950USD£3,042GBP
- Report
- October 2025
- 421 Pages
Global
From €6205EUR$6,995USD£5,387GBP
- Report
- May 2025
- 100 Pages
Global
From €5278EUR$5,950USD£4,582GBP
- Report
- November 2024
- 120 Pages
Global
From €5278EUR$5,950USD£4,582GBP
- Report
- June 2025
- 182 Pages
Global
From €3992EUR$4,500USD£3,466GBP
- Report
- October 2025
- 199 Pages
Global
From €3145EUR$3,545USD£2,730GBP
€3494EUR$3,939USD£3,034GBP
- Report
- October 2025
- 174 Pages
Global
From €5189EUR$5,850USD£4,505GBP
- Report
- April 2025
- 175 Pages
Global
From €3983EUR$4,490USD£3,458GBP
- Report
- March 2025
- 200 Pages
Global
From €3983EUR$4,490USD£3,458GBP
- Report
- November 2024
- 338 Pages
Global
From €4435EUR$5,000USD£3,851GBP
- Drug Pipelines
- April 2025
- 80 Pages
Global
From €1774EUR$2,000USD£1,540GBP
- Report
- May 2025
- 90 Pages
Global
From €3500EUR$4,227USD£3,145GBP

The CRISPR market is a subset of the genomics market that focuses on the use of CRISPR-Cas9 technology for gene editing. CRISPR-Cas9 is a powerful tool that enables scientists to make precise changes to the genome of living organisms. This technology has been used to develop treatments for a variety of diseases, as well as to create new crops and livestock. CRISPR-Cas9 technology has also been used to create gene drives, which are designed to spread a desired trait through a population.
The CRISPR market is highly competitive, with a number of companies offering products and services related to gene editing. These companies include Editas Medicine, Intellia Therapeutics, CRISPR Therapeutics, Caribou Biosciences, and ERS Genomics. These companies are developing a range of products, from gene editing tools to gene therapies, and are working to make CRISPR-Cas9 technology more accessible and affordable. Show Less Read more